Table 4.
Age-Related Trend of HPVs According to Different Periods in Women Under 30 with CIN3
| HPV Genotypes and Age-Groups | 2007–2010 n (%) | 2011–2014 n (%) | 2015–2018 n (%) | P value | |
|---|---|---|---|---|---|
| Sample Size (144) | Sample Size (180) | Sample Size (150) | |||
| HPV-16/18 | Age < 25 | 78 (77.2) | 38 (71.7) | 17 (68.0) | 0.284 |
| Age 25–29 | 34 (79.1) | 86 (67.7) | 82 (65.6) | 0.145 | |
| HPV-31/33/35/52/58/67* | Age < 25 | 12 (11.9) | 10 (18.9) | 5 (20.0) | 0.197 |
| Age 25–29 | 5 (11.6) | 22 (17.3) | 23 (18.4) | 0.364 | |
| HPV-39/45/59/68/70** | Age < 25 | 5 (5.0) | 1 (1.9) | 0 (0.0) | 0.159 |
| Age 25–29 | 2 (4.7) | 9 (7.1) | 4 (3.2) | 0.412 | |
| HPV-31/33/45/52/58*** | Age < 25 | 10 (9.9) | 9 (17.0) | 6 (24.0) | 0.048 |
| Age 25–29 | 4 (9.3) | 19 (15.0) | 18 (14.4) | 0.532 | |
| HPV-26/30/53/67/70/73/82/85**** | Age < 25 | 4 (4.0) | 0 (0.0) | 0 (0.0) | 0.107 |
| Age 25–29 | 3 (7.0) | 2 (1.6) | 2 (1.6) | 0.108 | |
| HPV-6/11/40/42/43/44/54/55/61***** | Age < 25 | 3 (3.0) | 3 (5.7) | 1 (4.0) | 0.604 |
| Age 25–29 | 0 (0.0) | 6 (4.7) | 1 (0.8) | 0.606 | |
Notes: *Genetically related to HPV16; **Genetically related to HPV18; ***High-risk- types included in the nonavalent vaccine; ****Possibly carcinogenic HPV; *****Low-risk HPV.
Abbreviations: HPV, Human Papillomavirus; CIN, cervical intraepithelial neoplasia.